The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
Houman Hemmati is under consideration to lead the FDA’s Center for Biologics Evaluation and Research. A final decision has ...
At a first meeting on pediatric gene and cell therapy trials, participants discussed when enrolling children before adults is ethical and when to wait.
The ACC has published a scientific statement regarding the use of gene editing therapy for cardiovascular disease.
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
Zacks Investment Research on MSN
Three best genomics stocks for your portfolio in 2026
An updated edition of the Feb. 20, 2026, article. Genomics involves a thorough study of genomes (an organism’s complete set ...
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Revolution Medicines Inc.’s treatment for an aggressive form of pancreatic cancer boosted patients’ survival in a late-stage trial, further validating the company that’s considered an attractive ...
With samples collected from millions of species, Basecamp Research is building the “ultimate medicine-making machine” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results